1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
"MRFF CTA and NHMRC – 2025 Australia-UK Platform Studies in Areas of Unmet Clinical Need Grant Opportunity (GO8535)" is currently closed and not accepting applications.
MRFF CTA and NHMRC – 2025 Australia-UK Platform Studies in Areas of Unmet Clinical Need Grant Opportunity (GO8535) is sponsored by National Health and Medical Research Council (NHMRC). This opportunity supports mission-aligned projects and measurable outcomes.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
NIHR/NHMRC/MRFF – 2025 Australia-UK Platform Studies in Areas of Unmet Clinical Need National Health & Medical Research Council (NHMRC) The National Institute for Health and Care Research (NIHR) UK, Medical Research Future Fund (MRFF), and National Health and Medical Research Council (NHMRC) Australia are inviting applications for ambitious platform trials (Phase 2 or 3) in areas of unmet medical need.
The platform must be internationally collaborative, with joint leads based in Australia (for the Australian-based component of the trial) and the UK (for the UK-based component of the trial). Existing platforms are not eligible to apply for further funding under this call, and should apply through other existing MRFF, NHMRC and NIHR funding schemes.
for the Australian-based component the maximum grant amount that can be requested is up to $5 million AUD over 7 years, with a total contribution of up to $15m AUD. for the NIHR UK-based component, there is approximately £2. 6m per award over 7 years, with a total contribution of up to £7.
8 million GBP. Applications to this funding opportunity will follow a three-stage application process. Australian investigators must be included in the application for funding submitted to the NIHR UK as required under the official call .
Investigators with Stage 1 and Stage 2 applications assessed as fundable by the NIHR UK must be invited to apply for either MRFF or NHMRC funding as described in the overview of the process below: Stage 1. Initial application to NIHR (January-July 2025) Applications that are jointly led by Australian and UK researchers are submitted to the NIHR through the NIHR’s UK electronic online system REALMS .
For application requirements, see the guidelines on the NIHR scheme page . Deadline: 23 July 2025 10:00 UK (UTC+1) / 19:00 AEST(UTC+10)) Stage 2. Full application to NIHR (October-November 2025) Top-ranked applicants are invited to the next stage to provide a full application to the NIHR UK via REALMS.
Deadline: 27 November 2025 (10:00 UK (UTC+0) / 21:00 AEDT (UTC+11)) Full applications are assessed and recommendation on applications considered fundable for the UK component proceeds. Stage 3. Application to NHMRC/MRFF (anticipated January-July 2026) NIHR UK provides a list of recommended applications to the Department of Health and Aged Care and the NHMRC.
Applicants are invited to apply for MRFF or NHMRC funding through the NHMRC online system Sapphire. Deadline: TBA, anticipated June 2026 Applications are reviewed and grant recommendations will be made. Final outcomes will be notified to the UK and Australian joint leads of all applications.
Note. Application resources for Australian applicants invited to apply for MRFF or NHMRC funding under this call will be made available when the scheme opens in Sapphire in 2026. Stage 1 Application Guidelines NIHR Application support, including templates and assessment criteria GrantConnect Forecast Opportunity (including draft guidelines) For questions, please contact the Pre-Award Health team via nhmrc@research.
uq. edu. au.
NIHR/NHMRC/MRFF – 2025 Australia-UK Platform Studies in Areas of Unmet Clinical Need Scheme and Sapphire queries If you are applying through UQ but are not a current UQ staff member, please contact the round team above so that you can be added to a mailing list for updates .
According to the current listing, eligibility includes: Australian researchers collaborating with UK research teams on clinical trials and studies in areas of unmet clinical need. Confirm the full requirements in the official notice before applying.
The published deadline was August 26, 2026, which has passed. Check the official notice for any future application windows before investing time in a proposal.
MRFF CTA and NHMRC – 2025 Australia-UK Platform Studies in Areas of Unmet Clinical Need Grant Opportunity (GO8535) is funded by National Health and Medical Research Council (NHMRC). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
CDMRP's FY26 portfolio funds 34 programs, and October 2026 is dense with full-application deadlines: PRCRP October 5, PCRP October 7, MRP October 14. Every one of them is gated behind a pre-application that closed months earlier. Here is what that two-step structure actually costs applicants, and how to be inside the gate for FY27.
Read articleOn September 4, 2026, HRSA awarded $11.2 million through the Rural Residency Planning and Development program to build 15 new physician residencies across 14 states. Since 2019 the program has invested nearly $77 million, producing 66 accredited programs and 818 approved positions. Here is what the conversion rate reveals, why the specialty mix is narrowing, and how to build a competitive application for the next cycle.
Read articleHRSA-27-017 closes September 29, 2026 and HRSA-27-084 closes November 16, with $20,960,000 and $16,000,000 respectively. The award floors and ceilings are not budget guesses — they are resident headcounts at the $160,000 interim per-resident rate. Read them that way and the eligibility question answers itself.
Read article